Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Relay Therapeutics | RLAY | Dec 24, 2024 | 4.23 | -2.53 |
Reliance | RS | Dec 24, 2024 | 270.98 | +0.33 |
Reliance Global | RELI | Dec 24, 2024 | 2.53 | -18.65 |
Relmada Therapeutics | RLMD | Dec 24, 2024 | 0.36 | -4.79 |
RELX ADR | RELX | Dec 24, 2024 | 45.89 | +0.66 |
Remitly Global | RELY | Dec 24, 2024 | 22.64 | +0.94 |
Renaissance Ipo ETF | IPO | Dec 24, 2024 | 45.19 | +1.59 |
RenaissanceRe | RNR | Dec 24, 2024 | 249.95 | +0.07 |
RenaissanceRe G Pref | RNR-G | Dec 24, 2024 | 16.82 | -0.36 |
RenaissanceRe Holding F Pref | RNR-F | Dec 24, 2024 | 23.00 | -0.48 |
Renalytix ADR | RNLX | Dec 24, 2024 | 0.20 | 0.00 |
Renasant | RNST | Dec 24, 2024 | 35.68 | +1.05 |
ReNew Energy Global A Shares | RNW | Dec 24, 2024 | 6.87 | -0.72 |
Renn Fund | RCG | Dec 24, 2024 | 2.40 | -0.83 |
Renovaro Biosciences | RENB | Dec 24, 2024 | 1.03 | -8.04 |
RenovoRx | RNXT | Dec 24, 2024 | 1.29 | +1.57 |
Rent The Runway A | RENT | Dec 24, 2024 | 8.14 | -0.12 |
Rentokil Initial ADR | RTO | Dec 24, 2024 | 25.30 | -0.08 |
Repare Therapeutics | RPTX | Dec 24, 2024 | 1.35 | 0.00 |
Repay A | RPAY | Dec 24, 2024 | 7.79 | +1.17 |
Repligen | RGEN | Dec 24, 2024 | 146.95 | +0.89 |
Replimune Group | REPL | Dec 24, 2024 | 12.50 | +1.30 |
ReposiTrak | TRAK | Dec 24, 2024 | 22.51 | +1.76 |
Republic Bancorp A | RBCAA | Dec 24, 2024 | 71.59 | +1.03 |
Republic Services | RSG | Dec 24, 2024 | 204.14 | +0.93 |
Research Frontiers | REFR | Dec 24, 2024 | 1.65 | +2.48 |
Research Solutions | RSSS | Dec 24, 2024 | 3.78 | -2.58 |
Reservoir Media | RSVR | Dec 24, 2024 | 9.07 | -0.33 |
ReShape Lifesciences | RSLS | Dec 24, 2024 | 4.46 | +4.69 |
Resideo Technologies | REZI | Dec 24, 2024 | 24.54 | +1.41 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.